Mark W. Drummond
University of Washington(US)Beatson West of Scotland Cancer Centre(GB)Hospital de São João(PT)
Publications by Year
Research Areas
Chronic Myeloid Leukemia Treatments, Myeloproliferative Neoplasms: Diagnosis and Treatment, Acute Myeloid Leukemia Research, Chronic Lymphocytic Leukemia Research, Eosinophilic Disorders and Syndromes
Most-Cited Works
- → Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis(2015)455 cited
- → Pacritinib vs Best Available Therapy, Including Ruxolitinib, in Patients With Myelofibrosis(2018)365 cited
- → Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia(2015)345 cited
- → Guideline for investigation and management of adults and children presenting with a thrombocytosis(2010)313 cited
- → Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial(2021)141 cited
- → Single-cell multi-omics identifies chronic inflammation as a driver of TP53-mutant leukemic evolution(2023)133 cited